Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Sep 1;98(5):1231–1236. doi: 10.1172/JCI118906

Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms.

R R Henry 1, T P Ciaraldi 1, L Abrams-Carter 1, S Mudaliar 1, K S Park 1, S E Nikoulina 1
PMCID: PMC507545  PMID: 8787686

Abstract

To determine whether glycogen synthase (GS) activity remains impaired in skeletal muscle of non-insulin-dependent diabetes mellitus (NIDDM) patients or can be normalized after prolonged culture, needle biopsies of vastus lateralis were obtained from 8 healthy nondiabetic control (ND) and 11 NIDDM subjects. After 4-6 wk growth and 4 d fusion in media containing normal physiologic concentrations of insulin (22 pM) and glucose (5.5 mM), both basal (5.21 +/- 0.79 vs 9.01 +/- 1.25%, P < 0.05) and acute insulin-stimulated (9.35 +/- 1.81 vs 16.31 +/- 2.39, P < 0.05) GS fractional velocity were reduced in NIDDM compared to ND cells. Determination of GS kinetic constants from muscle cells of NIDDM revealed an increased basal and insulin-stimulated Km(0.1) for UDP-glucose, a decreased insulin-stimulated Vmax(0.1) and an increased insulin-stimulated activation constant (A(0.5)) for glucose-6-phosphate. GS protein expression, determined by Western blotting, was decreased in NIDDM compared to ND cells (1.57 +/- 0.29 vs 3.30 +/- 0.41 arbitrary U/mg protein, P < 0.05). GS mRNA abundance also tended to be lower, but not significantly so (0.168 +/- 0.017 vs 0.243 +/- 0.035 arbitrary U, P = 0.08), in myotubes of NIDDM subjects. These results indicate that skeletal muscle cells of NIDDM subjects grown and fused in normal culture conditions retain defects of basal and insulin-stimulated GS activity that involve altered kinetic behavior and possibly reduced GS protein expression. We conclude that impaired regulation of skeletal muscle GS in NIDDM patients is not completely reversible in normal culture conditions and involves mechanisms that may be genetic in origin.

Full Text

The Full Text of this article is available as a PDF (199.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bak J. F., Møller N., Schmitz O., Saaek A., Pedersen O. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia. 1992 Aug;35(8):777–784. doi: 10.1007/BF00429100. [DOI] [PubMed] [Google Scholar]
  2. Beck-Nielsen H., Vaag A., Damsbo P., Handberg A., Nielsen O. H., Henriksen J. E., Thye-Rønn P. Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care. 1992 Mar;15(3):418–429. doi: 10.2337/diacare.15.3.418. [DOI] [PubMed] [Google Scholar]
  3. Blau H. M., Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5623–5627. doi: 10.1073/pnas.78.9.5623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bogardus C., Lillioja S., Stone K., Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest. 1984 Apr;73(4):1185–1190. doi: 10.1172/JCI111304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  7. Chen Y. H., Hansen L., Chen M. X., Bjørbaek C., Vestergaard H., Hansen T., Cohen P. T., Pedersen O. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes. 1994 Oct;43(10):1234–1241. doi: 10.2337/diabetes.43.10.1234. [DOI] [PubMed] [Google Scholar]
  8. Ciaraldi T. P., Abrams L., Nikoulina S., Mudaliar S., Henry R. R. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 1995 Dec;96(6):2820–2827. doi: 10.1172/JCI118352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DeFronzo R. A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991 Mar;14(3):173–194. doi: 10.2337/diacare.14.3.173. [DOI] [PubMed] [Google Scholar]
  10. Dent P., Lavoinne A., Nakielny S., Caudwell F. B., Watt P., Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature. 1990 Nov 22;348(6299):302–308. doi: 10.1038/348302a0. [DOI] [PubMed] [Google Scholar]
  11. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widén E., Schalin C., Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989 Aug 10;321(6):337–343. doi: 10.1056/NEJM198908103210601. [DOI] [PubMed] [Google Scholar]
  12. Ghosh S., Schork N. J. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes. 1996 Jan;45(1):1–14. doi: 10.2337/diab.45.1.1. [DOI] [PubMed] [Google Scholar]
  13. Groop L. C., Kankuri M., Schalin-Jäntti C., Ekstrand A., Nikula-Ijäs P., Widén E., Kuismanen E., Eriksson J., Franssila-Kallunki A., Saloranta C. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med. 1993 Jan 7;328(1):10–14. doi: 10.1056/NEJM199301073280102. [DOI] [PubMed] [Google Scholar]
  14. Henry R. R., Abrams L., Nikoulina S., Ciaraldi T. P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes. 1995 Aug;44(8):936–946. doi: 10.2337/diab.44.8.936. [DOI] [PubMed] [Google Scholar]
  15. Henry R. R., Ciaraldi T. P., Mudaliar S., Abrams L., Nikoulina S. E. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes. 1996 Apr;45(4):400–407. doi: 10.2337/diab.45.4.400. [DOI] [PubMed] [Google Scholar]
  16. Kuroyama H., Sanke T., Ohagi S., Furuta M., Furuta H., Nanjo K. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia. 1994 May;37(5):536–539. doi: 10.1007/s001250050144. [DOI] [PubMed] [Google Scholar]
  17. Majer M., Mott D. M., Mochizuki H., Rowles J. C., Pedersen O., Knowler W. C., Bogardus C., Prochazka M. Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia. 1996 Mar;39(3):314–321. doi: 10.1007/BF00418347. [DOI] [PubMed] [Google Scholar]
  18. Mandarino L. J., Wright K. S., Verity L. S., Nichols J., Bell J. M., Kolterman O. G., Beck-Nielsen H. Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest. 1987 Sep;80(3):655–663. doi: 10.1172/JCI113118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Orho M., Nikula-Ijäs P., Schalin-Jäntti C., Permutt M. A., Groop L. C. Isolation and characterization of the human muscle glycogen synthase gene. Diabetes. 1995 Sep;44(9):1099–1105. doi: 10.2337/diab.44.9.1099. [DOI] [PubMed] [Google Scholar]
  20. Roach R. J., Larner J. Covalent phosphorylation in the regulation glycogen synthase activity. Mol Cell Biochem. 1977 May 3;15(3):179–200. doi: 10.1007/BF01734108. [DOI] [PubMed] [Google Scholar]
  21. Sarabia V., Lam L., Burdett E., Leiter L. A., Klip A. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest. 1992 Oct;90(4):1386–1395. doi: 10.1172/JCI116005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schalin-Jäntti C., Härkonen M., Groop L. C. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes. 1992 May;41(5):598–604. doi: 10.2337/diab.41.5.598. [DOI] [PubMed] [Google Scholar]
  23. Seldin M. F., Mott D., Bhat D., Petro A., Kuhn C. M., Kingsmore S. F., Bogardus C., Opara E., Feinglos M. N., Surwit R. S. Glycogen synthase: a putative locus for diet-induced hyperglycemia. J Clin Invest. 1994 Jul;94(1):269–276. doi: 10.1172/JCI117317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shulman G. I., Rothman D. L., Jue T., Stein P., DeFronzo R. A., Shulman R. G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan 25;322(4):223–228. doi: 10.1056/NEJM199001253220403. [DOI] [PubMed] [Google Scholar]
  25. Skurat A. V., Wang Y., Roach P. J. Rabbit skeletal muscle glycogen synthase expressed in COS cells. Identification of regulatory phosphorylation sites. J Biol Chem. 1994 Oct 14;269(41):25534–25542. [PubMed] [Google Scholar]
  26. Thorburn A. W., Gumbiner B., Bulacan F., Brechtel G., Henry R. R. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest. 1991 Feb;87(2):489–495. doi: 10.1172/JCI115022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thorburn A. W., Gumbiner B., Bulacan F., Wallace P., Henry R. R. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest. 1990 Feb;85(2):522–529. doi: 10.1172/JCI114468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vaag A., Henriksen J. E., Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1992 Mar;89(3):782–788. doi: 10.1172/JCI115656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vestergaard H., Bjørbaek C., Andersen P. H., Bak J. F., Pedersen O. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes. 1991 Dec;40(12):1740–1745. doi: 10.2337/diab.40.12.1740. [DOI] [PubMed] [Google Scholar]
  30. Vestergaard H., Lund S., Larsen F. S., Bjerrum O. J., Pedersen O. Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1993 Jun;91(6):2342–2350. doi: 10.1172/JCI116466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wells A. M., Sutcliffe I. C., Johnson A. B., Taylor R. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes. 1993 Apr;42(4):583–589. doi: 10.2337/diab.42.4.583. [DOI] [PubMed] [Google Scholar]
  32. Zhang W., DePaoli-Roach A. A., Roach P. J. Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase. Arch Biochem Biophys. 1993 Jul;304(1):219–225. doi: 10.1006/abbi.1993.1342. [DOI] [PubMed] [Google Scholar]
  33. Zouali H., Velho G., Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med. 1993 May 27;328(21):1568–1569. doi: 10.1056/NEJM199305273282113. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES